Insulet Corp at Morgan Stanley Global Healthcare Conference Transcript
All righty. Thank you very much. It's [Patrick] on the U.S. medtech team here. And very excited to have Jim and Wayde, CEO and CFO of PODD, over here. And it's going to be a really interesting discussion, I think.
Disclosures, morganstanley.com/researchdisclosures, very exciting website. I expect to see all of you there. Reach out to your sales reps if you have any other questions.
And so with that, let's kick it off. I think you want to do some opening remarks, right?
Yes. Patrick, thank you very much, and thanks, everybody, for joining us today. It's great to have you all here. I'll just start with a couple of comments.
And first one is our business has fantastic momentum. We're coming off of a fantastic Q2 with record new customer starts, record revenue. We grew 32% year-over-year. And it's our fourth straight quarter of growth in the U.S. that starts with a 4. So we've had 4 straight quarters of U.S. growth at 40%-plus, which is really, really
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
